Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Peter Impey

- PMLiVE

Creative strategy in medical communications

By Georgia Hartnell

- PMLiVE

GSK and Vesalius partner on new Parkinson’s treatments in deal worth $650m

The alliance is aimed at developing treatments for Parkinson's and another neurodegeneration indication

- PMLiVE

ICR researchers identify potential treatment approach for acute myeloid leukaemia

More than 3,100 people are diagnosed with the aggressive blood cancer in the UK every year

- PMLiVE

Cutting through the maze of obstacles to liberate patient pathways

Digital and AI intelligence – advancing healthcare and demolishing access and equity barriers

- PMLiVE

Don’t miss out! Get a Sneak Peek at Next-Gen Life Science Education and Training Tools

From interactive case studies to AI-driven avatars, our free webinar dives into the tools defining tomorrow’s life sciences education. Last spots available – sign up now!

Impetus Digital

- PMLiVE

Novartis and Schrödinger to advance drug candidates in deal worth over $2.4bn

The companies will advance therapeutics for undisclosed targets in Novartis’ core areas

- PMLiVE

Merck KGaA/Abbisko share positive phase 3 results for pimicotinib in rare tumour type

The companies entered into a licensing agreement for the candidate in December last year

- PMLiVE

Is Gen AI ready for life sciences?

The explosive growth of Gen AI has caused plenty of consternation as well as celebration, but there’s no turning back the clock on this far-reaching technology

- PMLiVE

Roche and Flare Therapeutics enter oncology partnership worth over $1.8bn

The companies will aim to discover small molecule treatments aimed at previously undrugged transcription factor targets

- PMLiVE

AstraZeneca/Merck’s Koselugo shows promise in adults with neurofibromatosis type 1

The rare genetic condition affects an estimated 1.7 million people globally

- PMLiVE

J&J’s nipocalimab granted FDA breakthrough designation for Sjögren’s disease

The chronic autoimmune disease affects approximately four million people globally

- PMLiVE

Getting to the Heart of the Matter: Medscape Education at AHA 2024!

Come join Medscape Education at the American Heart Association (AHA) 2024 Scientific Sessions in Chicago, IL, from November 16-18 — a dynamic event packed with cutting-edge cardiology education that you...

Medscape Education

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links